Sudden Infant Death With a Subtle Autopsy Finding
A 4-month-old previously healthy boy is found unresponsive prone in his crib at 6 a.m. after being placed supine at 10 p.m. Resuscitation fails. There is no history of illness, trauma, or prior apnea. At autopsy, growth parameters are at the 50th percentile. External examination shows dependent lividity and no injuries. Internal examination reveals a mildly enlarged thymus, petechiae on the thymus and pleura, and a small amount of frothy fluid in the airways. The brain is mildly edematous. The parents ask whether the death could be due to a metabolic disorder and whether they should be tested.
1. How do you classify this death, and what is the role of the autopsy in distinguishing SIDS from other causes?
Read the worked answer
This presentation is classic for SIDS: age under 1 year, death during sleep, no antecedent symptoms, and an autopsy showing no lethal structural disease. The findings - thymic and pleural petechiae, frothy airway fluid, mild cerebral edema - are common nonspecific findings in SIDS and are not diagnostic of asphyxia or suffocation. They should be described but not overinterpreted.
The autopsy's role is exclusionary and evidentiary:
- Complete external and internal examination to exclude trauma, congenital heart disease, infection, and malformations.
- Scene investigation (sleep environment, bedding, position) is part of the death investigation; the prone position at discovery is a recognized risk factor even if placed supine.
- Ancillary testing guided by history: microbiology (blood, CSF, respiratory), metabolic screening (acylcarnitine profile, urine organic acids), and toxicology where indicated.
- Histology of myocardium (myocarditis), lungs (pneumonia), and brain (hemorrhage, malformation) helps exclude mimics.
SIDS remains a diagnosis of exclusion after integrating history, scene, and autopsy. The pathologist should state the classification explicitly and document negative findings that support it.
2. The parents ask about metabolic disease. What is the evidence base, and how would you counsel them and order testing?
Read the worked answer
Inborn errors of metabolism (notably fatty acid oxidation disorders such as MCAD deficiency) are a recognized but uncommon cause of sudden unexpected death in infancy. The probability is low in a well-grown infant with no prodrome, but it is not zero, and the consequences for the family are high.
Practical approach:
- Collect samples at autopsy: postmortem blood for acylcarnitine profile, urine or vitreous for organic acids, and bank DNA (or a fibroblast culture) for later molecular testing. Postmortem samples degrade, so timing matters.
- Liver and muscle histology may show microvesicular steatosis in fatty acid oxidation defects, but histology is insensitive; do not rely on it to exclude disease.
- Newborn screening records should be reviewed - many of these disorders are on expanded newborn panels, though false negatives occur.
- Counseling: explain that SIDS is the working diagnosis and that metabolic testing is being done for completeness and family risk assessment. If a disorder is found, the implications for siblings (autosomal recessive) are significant and genetic counseling is indicated.
A reasonable script: "The autopsy and scene findings are most consistent with SIDS. We are sending metabolic and genetic tests because a small number of sudden infant deaths are due to inherited disorders, and if one were present it would matter for your other children. We will contact you with results."
3. What findings at autopsy would have changed the classification, and how should the report handle the uncertain contribution of the prone position?
Read the worked answer
Findings that would reclassify the death include:
- Trauma: fractures, intracranial hemorrhage, retinal hemorrhages, bruises in nonmobile infants - raising concern for inflicted injury.
- Infection: pneumonia, myocarditis, meningitis, or sepsis with positive cultures and histologic corroboration.
- Congenital heart disease or other lethal malformation.
- Metabolic disease confirmed biochemically or molecularly.
- Asphyxia indicators: although petechiae and frothy fluid are nonspecific, a scene inconsistent with the reported sleep environment (e.g., wedged in bedding, overlaying) would shift the classification toward an asphyxial or undetermined death.
Regarding the prone position: the report should note it as a risk factor and describe the scene accurately, but should not attribute the death to asphyxia in the absence of corroborating findings. Wording such as "consistent with SIDS in the setting of prone sleeping" is defensible; "death due to asphyxia" is not supported by petechiae and frothy fluid alone. The pathologist should avoid language that implies fault while still documenting the environmental risk, and should recommend safe-sleep counseling for the family.